-
1
-
-
0037246825
-
Novel drug delivery systems for insulin: Clinical potential for use in the elderly
-
Belmin J, Valensi P. 2003. Novel drug delivery systems for insulin: Clinical potential for use in the elderly. Drugs Aging 20(4):303-312.
-
(2003)
Drugs Aging
, vol.20
, Issue.4
, pp. 303-312
-
-
Belmin, J.1
Valensi, P.2
-
2
-
-
0034938821
-
Syringe, pen, inhaler: The evolution of insulin therapy
-
Harsch IA, Hahn EG, Konturek PC. 2001. Syringe, pen, inhaler: The evolution of insulin therapy. Med Sci Monit 7(4):833-836.
-
(2001)
Med Sci Monit
, vol.7
, Issue.4
, pp. 833-836
-
-
Harsch, I.A.1
Hahn, E.G.2
Konturek, P.C.3
-
3
-
-
0033851983
-
Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer
-
Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T. 2000. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer. Diabetes Care 23(9):1343-1347.
-
(2000)
Diabetes Care
, vol.23
, Issue.9
, pp. 1343-1347
-
-
Heinemann, L.1
Klappoth, W.2
Rave, K.3
Hompesch, B.4
Linkeschowa, R.5
Heise, T.6
-
4
-
-
0035667147
-
Pulmonary peptide delivery: Effect of taste-masking excipients on leuprolide suspension metered-dose inhalers
-
Zheng JY, Fulu M, Lee DY, Barber TE, Adjei AL. 2001. Pulmonary peptide delivery: Effect of taste-masking excipients on leuprolide suspension metered-dose inhalers. Pharm Dev Technol 6(4): 521-530.
-
(2001)
Pharm Dev Technol
, vol.6
, Issue.4
, pp. 521-530
-
-
Zheng, J.Y.1
Fulu, M.2
Lee, D.Y.3
Barber, T.E.4
Adjei, A.L.5
-
5
-
-
0004663789
-
Developmental pharmaceutics of inhaled peptides and proteins. Inhalation delivery of therapeutic peptides and proteins
-
Adjei AL, Gupta PK. 1997. Developmental pharmaceutics of inhaled peptides and proteins. Inhalation delivery of therapeutic peptides and proteins. Lung Biol Health Dis 107:735-769.
-
(1997)
Lung Biol Health Dis
, vol.107
, pp. 735-769
-
-
Adjei, A.L.1
Gupta, P.K.2
-
7
-
-
0035719828
-
The lung as a route for systemic delivery of therapeutic proteins and peptides
-
Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N. 2001. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res 2:198-209.
-
(2001)
Respir Res
, vol.2
, pp. 198-209
-
-
Agu, R.U.1
Ugwoke, M.I.2
Armand, M.3
Kinget, R.4
Verbeke, N.5
-
9
-
-
0031046746
-
Peptide delivery via the pulmonary route: A valid approach for local and systemic delivery
-
Smith PL. 1997. Peptide delivery via the pulmonary route: A valid approach for local and systemic delivery. J Control Release 46:99-106.
-
(1997)
J Control Release
, vol.46
, pp. 99-106
-
-
Smith, P.L.1
-
10
-
-
0031560925
-
Preparation of peptide and protein powders for inhalation
-
Johnson KA. 1997. Preparation of peptide and protein powders for inhalation. Adv Drug Delivery Rev 26:3-15.
-
(1997)
Adv Drug Delivery Rev
, vol.26
, pp. 3-15
-
-
Johnson, K.A.1
-
11
-
-
0027957592
-
Drug delivery to the respiratory tract using dry powder inhalers
-
Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M. 1994. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 101:1-13.
-
(1994)
Int J Pharm
, vol.101
, pp. 1-13
-
-
Timsina, M.P.1
Martin, G.P.2
Marriott, C.3
Ganderton, D.4
Yianneskis, M.5
-
12
-
-
0031904113
-
Recent advances in pulmonary drug delivery using large, porous inhaled particles
-
Edwards DA, Ben-Jebria A, Langer R. 1998. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Phys 85:379-385.
-
(1998)
J Appl Phys
, vol.85
, pp. 379-385
-
-
Edwards, D.A.1
Ben-Jebria, A.2
Langer, R.3
-
13
-
-
50249149951
-
5 Myths about MDIs
-
Brown BAS. 2002. 5 Myths about MDIs. Drug Deliv 2(7):52-59.
-
(2002)
Drug Deliv
, vol.2
, Issue.7
, pp. 52-59
-
-
Brown, B.A.S.1
-
14
-
-
0031442496
-
Tetrafluoroethane (HFC 134a) propellant-driven aerosols of proteins
-
Brown AR, George DW. 1997. Tetrafluoroethane (HFC 134a) propellant-driven aerosols of proteins. Pharm Res 14(11):1542-1547.
-
(1997)
Pharm Res
, vol.14
, Issue.11
, pp. 1542-1547
-
-
Brown, A.R.1
George, D.W.2
-
15
-
-
0032935231
-
Formulation of a protein with propellant HFA 134a for aerosol delivery
-
Williams RO III, Liu J. 1998. Formulation of a protein with propellant HFA 134a for aerosol delivery. Eur J Pharm Sci 7:137-144.
-
(1998)
Eur J Pharm Sci
, vol.7
, pp. 137-144
-
-
Williams III, R.O.1
Liu, J.2
-
17
-
-
0031706442
-
The case for local immunosuppression in composite tissue allotransplantation
-
Shirbacheh MV, Jones JW, Breidenbach WC, McCabe S, Barker JH, Gruber SA. 1998. The case for local immunosuppression in composite tissue allotransplantation. Transplant Proc 30:2739-2742.
-
(1998)
Transplant Proc
, vol.30
, pp. 2739-2742
-
-
Shirbacheh, M.V.1
Jones, J.W.2
Breidenbach, W.C.3
McCabe, S.4
Barker, J.H.5
Gruber, S.A.6
-
18
-
-
0033810531
-
In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine
-
Mitruka SN, Won A, McCurry KR, Zeevi A, McKaveney T, Venkataramanan R, Iacono A, Griffith BP, Burckart GJ. 2000. In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine. J Heart Lung Transplant 19(10):969-975.
-
(2000)
J Heart Lung Transplant
, vol.19
, Issue.10
, pp. 969-975
-
-
Mitruka, S.N.1
Won, A.2
McCurry, K.R.3
Zeevi, A.4
McKaveney, T.5
Venkataramanan, R.6
Iacono, A.7
Griffith, B.P.8
Burckart, G.J.9
-
19
-
-
0035946943
-
Effects of cyclosporin A administered into the airways against antigen-induced airway inflammation and hyperreactivity in the rat
-
Underwood SL, McMillan S, Reeves R, Hunt J, Brealey CJ, Webber S, Foster M, Sargent CA. 2001. Effects of cyclosporin A administered into the airways against antigen-induced airway inflammation and hyperreactivity in the rat. Eur J Pharm 420:165-173.
-
(2001)
Eur J Pharm
, vol.420
, pp. 165-173
-
-
Underwood, S.L.1
McMillan, S.2
Reeves, R.3
Hunt, J.4
Brealey, C.J.5
Webber, S.6
Foster, M.7
Sargent, C.A.8
-
20
-
-
0033744481
-
Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients
-
Rohatagi S, Calic F, Harding N, Ozoux ML, Bouriot JP, Kirkesseli S, DeLeij L, Jensen B. 2000. Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients. J Clin Pharmacol 40:1211-1226.
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 1211-1226
-
-
Rohatagi, S.1
Calic, F.2
Harding, N.3
Ozoux, M.L.4
Bouriot, J.P.5
Kirkesseli, S.6
DeLeij, L.7
Jensen, B.8
-
21
-
-
0344951280
-
Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients
-
Burckart GJ, Smaldone GC, Eldon MA, Venkataramanan JD, Zeevi A, McCurry K, McKaveney TP, Corcoran TE, Griffith BP, Iacono AT. 2003. Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients. Pharm Res 20(2):252-256.
-
(2003)
Pharm Res
, vol.20
, Issue.2
, pp. 252-256
-
-
Burckart, G.J.1
Smaldone, G.C.2
Eldon, M.A.3
Venkataramanan, J.D.4
Zeevi, A.5
McCurry, K.6
McKaveney, T.P.7
Corcoran, T.E.8
Griffith, B.P.9
Iacono, A.T.10
-
22
-
-
0038731994
-
Evaluation of a new aerodynamic particle sizer for MDI distribution measurements
-
Byron PR, Dalby RN, Farr SJ, Peart J, editors. Raleigh, NC: Serentec Press
-
Myrdal PB, Gupta A, Stein SW, Gabrio BJ, Beck TJ. 2002. Evaluation of a new aerodynamic particle sizer for MDI distribution measurements. In: Byron PR, Dalby RN, Farr SJ, Peart J, editors. Respiratory drug delivery VIII. Raleigh, NC: Serentec Press, pp 663-666.
-
(2002)
Respiratory Drug Delivery VIII
, pp. 663-666
-
-
Myrdal, P.B.1
Gupta, A.2
Stein, S.W.3
Gabrio, B.J.4
Beck, T.J.5
-
23
-
-
0038394096
-
Physical tests and determinations 〈601〉 aerosols, metered dose inhalers, and dry powders
-
U.S. Pharmacopeia. 1996. Physical tests and determinations 〈601〉 aerosols, metered dose inhalers, and dry powders. Pharmac Forum 22:3065-3095.
-
(1996)
Pharmac Forum
, vol.22
, pp. 3065-3095
-
-
-
24
-
-
0038055572
-
Comparison of the TSI model 3306 impactor inlet with the Andersen Cascade Impactor; solution metered dose inhalers
-
Byron PR, Dalby RN, Farr SJ, Peart J, editors. Raleigh, NC: Serentec Press
-
Gupta A, Myrdal PB, Stein SW, Gabrio BJ, Beck TJ. 2002. Comparison of the TSI model 3306 impactor inlet with the Andersen Cascade Impactor; solution metered dose inhalers. In: Byron PR, Dalby RN, Farr SJ, Peart J, editors. Respiratory drug delivery VIII. Raleigh, NC: Serentec Press, pp 659-662.
-
(2002)
Respiratory Drug Delivery VIII
, pp. 659-662
-
-
Gupta, A.1
Myrdal, P.B.2
Stein, S.W.3
Gabrio, B.J.4
Beck, T.J.5
-
25
-
-
0031584680
-
High-performance liquid chromatographic analysis of cyclosporin A and its oral solutions
-
Husek A. 1997. High-performance liquid chromatographic analysis of cyclosporin A and its oral solutions. J Chromatogr A 759:217-224.
-
(1997)
J Chromatogr A
, vol.759
, pp. 217-224
-
-
Husek, A.1
-
26
-
-
0038471182
-
Evaluation of a new aerodynamic particle sizer spectrometer for size distribution measurement of solution metered dose inhalers
-
Stein SW, Myrdal PB, Gabrio BJ, Obereit D, Beck TJ. 2003. Evaluation of a new aerodynamic particle sizer spectrometer for size distribution measurement of solution metered dose inhalers. J Aerosol Med 16(2):107-119.
-
(2003)
J Aerosol Med
, vol.16
, Issue.2
, pp. 107-119
-
-
Stein, S.W.1
Myrdal, P.B.2
Gabrio, B.J.3
Obereit, D.4
Beck, T.J.5
-
27
-
-
0038471153
-
Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers
-
Gupta A, Stein SW, Myrdal PB. 2003. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. J Aerosol Med 16(2):167-174.
-
(2003)
J Aerosol Med
, vol.16
, Issue.2
, pp. 167-174
-
-
Gupta, A.1
Stein, S.W.2
Myrdal, P.B.3
|